Jump to navigation
About
Mission and Values
Leadership Team
Board of Directors
Medical Advisors
Focus
Hyperoxaluria
Systemic Oxalosis
Hyperuricemia
Publications
Products
Reloxaliase
ALLN-346
Pipeline
FAQs
Investors
Overview
News Releases
Events and Presentations
Stock Information
Analyst Coverage
Corporate Governance
SEC Filings
Shareholder Services
Careers
Contact
You are here
Home
›
About
Leadership Team
Louis Brenner, M.D.
President and Chief Executive Officer
Hugh Wight
Senior Vice President, Technical Operations
Geoffrey Swire
Acting Chief Operating Officer and Senior Vice President, Corporate Development
David J. Clark, M.D.
Chief Medical Officer
Alicja Januszewicz, Ph.D.
Vice President, People & Culture
Richard Katz, M.D.
Chief Financial Officer